BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10846322)

  • 1. Research on regimens for early medical abortion.
    von Hertzen H
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):133-6, 150. PubMed ID: 10846322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to mifepristone regimens for medical abortion.
    Pymar HC; Creinin MD
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S54-64. PubMed ID: 10944370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical abortion alternatives to mifepristone.
    Creinin MD; Pymar HC
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):127-32, 150. PubMed ID: 10846321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review.
    Chen QJ; Hou SP; Meads C; Huang YM; Hong QQ; Zhu HP; Cheng LN;
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):247-54. PubMed ID: 21741747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.
    Newhall EP; Winikoff B
    Am J Obstet Gynecol; 2000 Aug; 183(2 Suppl):S44-53. PubMed ID: 10944369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication abortion.
    Bartz D; Goldberg A
    Clin Obstet Gynecol; 2009 Jun; 52(2):140-50. PubMed ID: 19407520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical termination for pregnancy in early first trimester (≤ 63 days) using combination of mifepristone and misoprostol or misoprostol alone: a systematic review.
    Abubeker FA; Lavelanet A; Rodriguez MI; Kim C
    BMC Womens Health; 2020 Jul; 20(1):142. PubMed ID: 32635921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of medical abortion: a meta-analysis.
    Kahn JG; Becker BJ; MacIsaa L; Amory JK; Neuhaus J; Olkin I; Creinin MD
    Contraception; 2000 Jan; 61(1):29-40. PubMed ID: 10745067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone dose in the regimen with misoprostol for medical abortion.
    Marions L
    Contraception; 2006 Jul; 74(1):21-5. PubMed ID: 16781255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical abortion.
    Bardin CW; Robbins A; O'Connor BM; Spitz I
    Curr Ther Endocrinol Metab; 1997; 6():305-11. PubMed ID: 9174759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.